These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 10516800

  • 21. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.
    Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T.
    Proc Natl Acad Sci U S A; 1999 Nov 09; 96(23):13432-7. PubMed ID: 10557338
    [Abstract] [Full Text] [Related]

  • 22. Late potentials in the signal-averaged electrocardiogram in schizophrenia patients maintained on antipsychotic agents: a preliminary naturalistic study.
    Nahshoni E, Strasberg B, Imbar S, Rotem O, Gur S, Hermesh H, Weizman A.
    Eur Neuropsychopharmacol; 2010 Mar 09; 20(3):146-52. PubMed ID: 20053540
    [Abstract] [Full Text] [Related]

  • 23. Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.
    Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS.
    J Proteome Res; 2012 Aug 03; 11(8):4338-50. PubMed ID: 22800120
    [Abstract] [Full Text] [Related]

  • 24. [3 years of risperidone: from innovation to example].
    Nervenarzt; 1997 Apr 03; 68(4 Suppl Von Der In):1-4. PubMed ID: 9442496
    [No Abstract] [Full Text] [Related]

  • 25. [Risperidon: an advance for schizophrenic patients. Why new neuroleptics?].
    Nervenarzt; 1994 May 03; 65(5 Suppl [risperid]):1-4. PubMed ID: 9131087
    [No Abstract] [Full Text] [Related]

  • 26. Neurological soft signs and response to risperidone in chronic schizophrenia.
    Smith RC, Kadewari RP.
    Biol Psychiatry; 1996 Nov 15; 40(10):1056-9. PubMed ID: 8915566
    [No Abstract] [Full Text] [Related]

  • 27. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.
    Abou El-Magd RM, Park HK, Kawazoe T, Iwana S, Ono K, Chung SP, Miyano M, Yorita K, Sakai T, Fukui K.
    J Psychopharmacol; 2010 Jul 15; 24(7):1055-67. PubMed ID: 19329549
    [Abstract] [Full Text] [Related]

  • 28. [Development of new antipsychotic drugs].
    Vanden Bussche G, Gelders YG, Heylen SL.
    Acta Psiquiatr Psicol Am Lat; 1990 Jul 15; 36(1-2):13-25. PubMed ID: 2127339
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment with risperidone of a case of spontaneous orgasm].
    Pastrana JI, Carrasco JL.
    Actas Esp Psiquiatr; 1999 Jul 15; 27(2):133-5. PubMed ID: 10380155
    [Abstract] [Full Text] [Related]

  • 31. [A new drug risperidone for treatment of psychosis].
    Tiihonen J.
    Duodecim; 1995 Jul 15; 111(20):1911-2. PubMed ID: 9841141
    [No Abstract] [Full Text] [Related]

  • 32. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
    Cai HL, Zhu RH, Li HD, Zhang XH, Hu L, Yang W, Ye HS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct 01; 34(7):1273-8. PubMed ID: 20637820
    [Abstract] [Full Text] [Related]

  • 33. Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia.
    Takahashi N, Terao T, Oga T, Okada M.
    Neuropsychobiology; 1999 Oct 01; 39(2):81-5. PubMed ID: 10072664
    [Abstract] [Full Text] [Related]

  • 34. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct 01; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract] [Full Text] [Related]

  • 35. Telephone support service helps keep schizophrenics on track.
    Healthc Demand Dis Manag; 1997 Jun 01; 3(6):91-3. PubMed ID: 10174903
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum concentrations and clinical effects of risperidone in schizophrenic patients in Singapore--a preliminary report.
    Lee HS, Tan CH, Khoo YM, Chee KT, Wong KE, Chong SA, Mahendran R, Yap JL, Low BL, Choo CH, Chan A.
    Br J Clin Pharmacol; 1999 Apr 01; 47(4):460-1. PubMed ID: 10366241
    [No Abstract] [Full Text] [Related]

  • 38. Different mechanisms of risperidone result in improved interpersonal trust, social engagement and cooperative behavior in patients with schizophrenia compared to trifluoperazine.
    Tse WS, Wong AS, Chan F, Pang AH, Bond AJ, Chan CK.
    Psychiatry Clin Neurosci; 2016 May 01; 70(5):218-26. PubMed ID: 26864920
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.